Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Plasma Protein Therapeutics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Plasma Protein Therapeutics Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Plasma Protein Therapeutics Market?
Baxter International
Biotest
CSL Behring
China Biologics
GRIFOLS, S.A.
Kedrion
Octapharma USA, Inc.
Shire Plc.
...
Major Type of Plasma Protein Therapeutics Covered in XYZResearch report:
Coagulation Factors
Immunoglobulins
Albumins
C1 esterase Inhibitors
Application Segments Covered in XYZResearch Market
Hemophilia
Primary Immunodeficiency Disorder
Idiopathic Thrombocytopenic Purpura
Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids)
Hereditary Angioedema
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Request Sample 
Request Discount 
Inquire Before BuyTable of Contents
Global Plasma Protein Therapeutics Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Coagulation Factors -Product Introduction and Major Manufacturers
1.1.2 Immunoglobulins -Product Introduction and Major Manufacturers
1.1.3 Albumins -Product Introduction and Major Manufacturers
1.1.4 C1 esterase Inhibitors -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.1.1 China Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.1.2 China Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.2.1 EU Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.2.2 EU Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.3.1 USA Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.3.2 USA Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.4.1 Japan Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.4.2 Japan Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.5.1 India Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.5.2 India Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.6.1 Southeast Asia Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.7.1 South America Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.7.2 South America Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Plasma Protein Therapeutics Status and Prospect (2015-2026)
2.8.1 Plasma Protein Therapeutics Market Size and Growth Rate (2015-2026)
2.8.2 Plasma Protein Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Plasma Protein Therapeutics Market Assessment by Segment
3.1 Global Plasma Protein Therapeutics Capacity and Growth Rate
3.2 Global Plasma Protein Therapeutics Sales by Type
3.3 Global Plasma Protein Therapeutics Sales Revenue by Type
3.4 Global Plasma Protein Therapeutics Consumption by Application
4 Global Plasma Protein Therapeutics Market Assessment by Regions
4.1 Global Plasma Protein Therapeutics Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Plasma Protein Therapeutics Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Plasma Protein Therapeutics Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Plasma Protein Therapeutics Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Plasma Protein Therapeutics Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Plasma Protein Therapeutics Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Plasma Protein Therapeutics Sales Market Share of Manufacturers (2019-2020)
6.3 Global Plasma Protein Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)
7 Plasma Protein Therapeutics Competitive Analysis
7.1 Baxter International
7.1.1 Baxter International Company Profiles
7.1.2 Baxter International Product Introduction
7.1.3 Baxter International Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Biotest
7.2.1 Biotest Company Profiles
7.2.2 Biotest Product Introduction
7.2.3 Biotest Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 CSL Behring
7.3.1 CSL Behring Company Profiles
7.3.2 CSL Behring Product Introduction
7.3.3 CSL Behring Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 China Biologics
7.4.1 China Biologics Company Profiles
7.4.2 China Biologics Product Introduction
7.4.3 China Biologics Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 GRIFOLS, S.A.
7.5.1 GRIFOLS, S.A. Company Profiles
7.5.2 GRIFOLS, S.A. Product Introduction
7.5.3 GRIFOLS, S.A. Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Kedrion
7.6.1 Kedrion Company Profiles
7.6.2 Kedrion Product Introduction
7.6.3 Kedrion Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Octapharma USA, Inc.
7.7.1 Octapharma USA, Inc. Company Profiles
7.7.2 Octapharma USA, Inc. Product Introduction
7.7.3 Octapharma USA, Inc. Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Shire Plc.
7.8.1 Shire Plc. Company Profiles
7.8.2 Shire Plc. Product Introduction
7.8.3 Shire Plc. Plasma Protein Therapeutics Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
8 Conclusion
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Healthcare and Pharmaceuticals | Pages : 198 |
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Healthcare and Pharmaceuticals | Pages : 200 |
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Healthcare and Pharmaceuticals | Pages : 214 |
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Agriculture, Food and Beverages | Pages : 190 |
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Healthcare and Pharmaceuticals | Pages : 197 |
We are happy to help! Call or write to us
